News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–49
Matches
49
Sources here
9
Companies here
1
Search results Stored financial headlines

Active search

49 matching headlines

Ticker or company: ROIVMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

MarketBeat Earnings Main company 🇺🇸 United States

Allspring Global Investments Holdings LLC Buys New Stake in Roivant Sciences Ltd. $ROIV

Allspring Global Investments Holdings LLC initiated a new position in Roivant Sciences Ltd. (NASDAQ:ROIV) during the first quarter, acquiring 142,134 shares valued at approximately $3.96 million. Institutional ownership of Roivant Sciences is significant, with roughly 64.76% of the stock held by hedge funds and …

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Deals and strategy Main company 🇺🇸 United States

Dimensional Fund Advisors LP Sells 1,771,602 Shares of Roivant Sciences Ltd. $ROIV

Dimensional Fund Advisors LP decreased its stake in Roivant Sciences Ltd. by 19.2% during the first quarter, selling over 1.7 million shares. Despite this, other institutional investors like Goldman Sachs and UBS AM increased their holdings. Company insiders also sold significant shares, though institutional …

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Moomoo Analyst action Main company 🇺🇸 United States

Piper Sandler Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $40

Piper Sandler has reiterated its Buy rating on Roivant Sciences (ROIV.US) and maintained its target price at $40. This continued endorsement suggests the firm's confidence in the company's future performance and valuation. The unchanged target price indicates that Piper Sandler believes the stock has …

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Roivant to Host Immunovant’s Aug. 6 Business Update Webcast

Immunovant (Nasdaq: IMVT) announced it will report its first-quarter financial results for the period ended June 30, 2026, on Thursday, August 6, 2026, before the market opens. Roivant Sciences (ROIV), Immunovant’s majority stockholder, will host a conference call and webcast at 8:00 a.m. ET …

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026
www.marketscreener.com Earnings Main company 🇺🇸 United States

Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

Roivant (Nasdaq: ROIV) is set to report its financial results for the first quarter ending June 30, 2026, and provide a business update on Thursday, August 6, 2026. The company will host a live conference call and webcast at 8:00 a.m. ET. Roivant is …

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com India Market update Main company 🇺🇸 United States

Form 4 Roivant Sciences Ltd. For: 21 July

This article announces the filing of Form 4 for Roivant Sciences Ltd. on July 21. It also includes standard disclaimers about the high risks involved in trading financial instruments and cryptocurrencies, emphasizing that the provided data may not be real-time or accurate and is …

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Roivant Sciences (ROIV) grants director Oren Ilan 775 fully vested shares

Roivant Sciences Ltd. director Oren Ilan was granted 775 Common Shares on July 17, 2026, under the company’s Non-Employee Director Compensation Plan. These shares were fully vested immediately upon grant at a price of $0.0000 per share, increasing his direct holdings to 121,004 Common …

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Roivant Sciences (ROIV) director granted 543 fully vested common shares

Roivant Sciences Ltd. director Melissa B. Epperly was granted 543 fully vested Common Shares on July 17, 2026, as part of the company’s Non-Employee Director Compensation Plan. This transaction increased her direct holdings to 17,017 Common Shares. The grant was reported in an SEC …

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Traders Daily Market update Main company 🇺🇸 United States

Responsive Playbooks and the ROIV Inflection

This article provides an in-depth AI-driven analysis of Roivant Sciences Ltd. (NASDAQ: ROIV), highlighting weak near-term sentiment despite potential long-term strength. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored to different risk profiles. The analysis also includes multi-timeframe signal analysis, identifying …

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Simply Wall Street Balance sheet Main company 🇺🇸 United States

ROIV - overprices legal wins and pipeline, ignoring fierce anti-FcRn competition, cash redeployment drag, and holding discounts.

This article argues that Roivant Sciences (ROIV) is overvalued, with its stock price failing to account for the speculative nature of its IP litigation, intense competition in the anti-FcRn market, the challenges of redeploying its significant cash pile into unproven assets, and the inherent …

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Kavout | AI Guidance Main company 🇺🇸 United States

Why is Billionaire Joe Edelman Bullish on Roivant Sciences (ROIV)

Billionaire investor Joe Edelman is bullish on Roivant Sciences (ROIV) due to its strengthened financial position following a $2.25 billion settlement with Moderna, providing significant capital for pipeline development. The company's unique "Vant" model allows for focused drug development, and its robust late-stage pipeline, …

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Sharemaestro News Company research Main company 🇺🇸 United States

Roivant’s 52-week Trend Signal holds near the high, but the latest push is only average-volume

ROIV added 2.4% for the week and remains within 2.8% of its 52-week high, with biotechnology breadth supportive but volume confirmation still measured.

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Sharemaestro News Company research Main company 🇺🇸 United States

Roivant’s near-high biotech advance is strong on price, less convincing on activity pressure

ROIV ended the week at $31.43, only 4.2% below its 52-week high, but the latest move came on 0.9x average volume and a negative activity-pressure read.

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context